Hyperliquid treasury company increases token buying strategy to $2.5 billion as shares run out

Hyperliquid Strategies, a Nasdaq-listed company using equity sales to build a treasury of Hyperliquids $HYPE token, has expanded its committed-equity facility with Chardan Capital Markets to $2.5 billion from $1 billion.　　The immediate runway before a new dilution constraint applies is far smaller than the headline commitment. Hyperliquid Strategies annual report disclosed $646.6 million of gross facility proceeds through June 30, followed by another $117.1 million raised through facility shares after quarter-end. Together, those figures show at least $763.7 million of proceeds, leaving no more than about $236.3 million before aggregate sales reach $1 billion. Any later sales would reduce that headroom, and the September 1 filing did not provide an updated utilization total.　　Once aggregate facility sales pass $1 billion, the issue price becomes decisive. Under the operative amendment, Hyperliquid Strategies cannot complete a sale if doing so would take the aggregate number of facility shares issued at prices below $12.02 above 42,641,847. That exchange cap equals 19.99% of the companys pre-amendment voting power or outstanding common shares. Issuance above the cap requires stockholder approval unless that approval is not required under Nasdaq rules.　　The restriction does not, however, translate into a clean dollar ceiling. Shares sold at $12.02 or more do